logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Ahmed O. Kaseb

The University of Texas MD Anderson Cancer Center

67H指数
548论文数
2.6W被引数
收录论文 159
发表时间
logo
Durvalumab with Gemcitabine and Oxaliplatin in Advanced Biliary Tract Cancerdurvalumab联合吉西他滨和奥沙利铂治疗晚期胆道癌
errCancers
IF4.4
err2026-06-11
err0
errOAAI
errMakenna A. Smack; Jane E. Rogers; Lianchun Xiao; Sunyoung S. Lee; Shubham Pant; Ahmed O. Kaseb; Brandon G. Smaglo; Victoria Higbie; Zishou Ian Hu; Amy An; Milind Javle
err分享
err收藏
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response放疗后肝内胆管癌增强变化的可测量影像学改变反映了反应的物理机制
errnpj Systems Biology and Applications
IF3.5
err2025-12-12
err0
errOAAI
errBrian De; Prashant Dogra; Mohamed Zaid; Dalia Elganainy; Kevin Sun; Ahmed M. Amer; Charles Wang; Michael K. Rooney; Enoch Chang; Hyunseon C. Kang; Zhihui Wang; Priya Bhosale; Bruno C. Odisio; Timothy E. Newhook; Ching-Wei D. Tzeng; Hop S. Tran Cao; Yun S. Chun; Jean-Nicholas Vauthey; Sunyoung S. Lee; Ahmed Kaseb; Kanwal Raghav; Milind Javle; Bruce D. Minsky; Sonal S. Noticewala; Emma B. Holliday; Grace L. Smith; Albert C. Koong; Prajnan Das; Vittorio Cristini; Ethan B. Ludmir; Eugene J. Koay
err分享
err收藏
Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic and Diagnostic Biomarker in Hepatocellular Carcinoma循环成纤维细胞生长因子21 (FGF21) 作为肝细胞癌的预后和诊断生物标志物
errJournal of Hepatocellular Carcinoma
IF3.4
err2025-12-10
err0
errOAAI
errJoe R Eid; Merih Yalciner; Lianchun Xiao; Ryan Sun; Mahesh Kumar Kannan; Manal Hassan; Asif Rashid; Shadi Chamseddine; Hop S Tran Cao; Hesham M Amin; Ahmed O Kaseb
err分享
err收藏
Evaluating the role of preoperative serum insulin-like growth factor 1 as a predictor of survival and recurrence for patients with resectable hepatocellular carcinoma评估术前血清胰岛素样生长因子1作为可切除肝细胞癌患者生存和复发预测指标的作用
errJOURNAL OF GASTROINTESTINAL SURGERY
IF2.4
err2025-11-01
err0
errOAAI
errEid, Joe; Haddad, Antony; Hassan, Manal; Amin, Hesham M.; Newhook, Timothy E.; Chun, Yun Shin; Tzeng, Ching-Wei D.; Vauthey, Jean-Nicolas; Cao, Hop S. Tran; Kaseb, Ahmed O.
err分享
err收藏
Perioperative camrelizumab plus rivoceranib versus surgery in resectable hepatocellular carcinoma围手术期卡瑞利zumab联合瑞戈非尼 versus 手术治疗可切除肝细胞癌
errThe Lancet
IF97.3
err2025-10-19
err0
PREAI
errAhmed Kaseb; Timothy M Pawlik
err分享
err收藏
Circulating Fibroblast Growth Factor 21 (FGF21) as a Prognostic Biomarker in Hepatocellular Carcinoma循环成纤维细胞生长因子21（FGF21）作为肝细胞癌的预后生物标志物
errAMERICAN JOURNAL OF GASTROENTEROLOGY
IF7.6
err2025-10-01
err0
PREAI
errEid, Joe R.; Yalciner, Merih; Xiao, Lianchun; Sun, Ryan; Kannan, Mahesh Kumar; Hassan, Manal; Rashid, Asif; Singer, Emad; Amin, Hesham M.; Kaseb, Ahmed O.
err分享
err收藏
Somatostatin Receptor 2 Overexpression in Hepatocellular Carcinoma: Implications for Cancer Biology and Therapeutic Applications生长抑素受体2在肝细胞癌中的过表达：对癌症生物学和治疗应用的意义
errCurrent Oncology 2025, Vol. 32, Page 512
IF0
err2025-09-29
err0
errOAAI
errServando Hernandez Vargas; Solmaz Aghaamiri; Jack T. Adams; Tyler M. Bateman; Belkacem Acidi; Sukhen C. Ghosh; Vahid Khalaj; Ahmed O. Kaseb; Hop S. Tran Cao; Majid Momeny; Ali Azhdarinia
err分享
err收藏
Linkage disequilibrium score regression identifies genetic correlations between hepatocellular carcinoma and clinically relevant traits连锁不平衡评分回归识别肝细胞癌与临床相关性状之间的遗传相关性
errInternational Journal of Cancer
IF4.7
err2025-09-27
err0
errOAAI
errYounghun Han; Vikram R. Shaw; Jinyoung Byun; Aaron P. Thrift; Catherine Zhu; Donghui Li; Rikita I. Hatia; Robin Kate Kelley; Sean P. Cleary; Anna S. Lok; Paige M. Bracci; Jennifer B. Permuth; Roxana Bucur; Jennifer Knox; Jian-Min Yuan; Amit G. Singal; Prasun K. Jalal; R. Mark Ghobrial; Yuko Kono; Dimpy P. Shah; Mindie H. Nguyen; Neehar D. Parikh; Richard Kim; Hui-Chen Wu; Hashem El-Serag; Ping Chang; Yun Shin Chun; Jian Gu; Chad Huff; Asif Rashid; Lu-Yu Hwang; Alison P. Klein; Saira A. Khaderi; Ahmed O. Kaseb; Kathrine A. McGlynn; Lewis R. Roberts; Manal M. Hassan; Christopher I. Amos
err分享
err收藏
Comprehensive Review of Transarterial Chemoembolization Plus Systemic Therapy in Advanced Hepatocellular CarcinomaAkyildiz, A.; Yavuz, B.G.; Ismayilov, R.; Buyukaksoy, M.; Sozen, S.; Eid, J.R.; Avritscher, R.; Sunyoung, L.; Yalcin, S.; Kaseb, A.O. 肝动脉化疗栓塞术联合全身治疗在晚期肝细胞癌中的综合综述。J. Gastrointest. Cancer 2025, 56, 194. [Google Scholar] [CrossRef]
errJOURNAL OF GASTROINTESTINAL CANCER
IF1.6
err2025-09-27
err1
PREAI
errAkyildiz, Arif; Yavuz, Betul Gok; Ismayilov, Rashad; Buyukaksoy, Muge; Sozen, Sena; Eid, Joe Ramzi; Avritscher, Rony; Sunyoung, Lee; Yalcin, Suayib; Kaseb, Ahmed O.
err分享
err收藏
Local Control and Extended Survival in Locally Advanced Hepatocellular Carcinoma局部控制和延长生存期在局部晚期肝细胞癌中的应用
errJAMA ONCOLOGY
IF20.1
err2025-04-10
err0
PREAI
errSherry, Alexander D.; Kaseb, Ahmed O.
err分享
err收藏
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial (vol 30, pg 807, 2024)基因组生物标志物预测阿替利珠单抗联合贝伐珠单抗免疫治疗在肝细胞癌中的疗效：来自IMbrave150试验的见解（卷30，页807，2024）
errCLINICAL AND MOLECULAR HEPATOLOGY
IF16.9
err2025-02-27
err0
errOAAI
errYim, Sun Young; Lee, Sung Hwan; Baek, Seung-Woo; Sohn, Bohwa; Jeong, Yun Seong; Kang, Sang-Hee; Park, Kena; Park, Hyewon; Lee, Sunyoung S.; Kaseb, Ahmed O.; Park, Young Nyun; Leem, Sun-Hee; Curran, Michael A.; Kim, Ji Hoon; Lee, Ju-Seog
err分享
err收藏
Outcomes of durvalumab with or without tremelimumab in routine clinical practice according to HIMALAYA Trial Eligibility: preliminary results of the international DT-real study
errDIGESTIVE AND LIVER DISEASE
IF3.8
err2025-02-01
err0
PREAI
errCelsa, C.; Nishida, N.; Chamseddine, S. M.; Arvind, A.; Li, M.; Toyoda, H.; Ulahannan, S.; Fulgenzi, C. A. M.; Manfredi, G. F.; D'Alessio, A.; Stefanini, B.; Cabibbo, G.; Camma, C.; Scheiner, B.; Rimassa, L.; Kelley, R. K.; Singal, A. G.; Kaseb, A. O.; Kudo, M.; Pinato, D. J.
err分享
err收藏
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United StatesRegorafenib治疗不可切除的肝细胞癌患者的耐受性和有效性: 来自美国的真实数据
errJOURNAL OF HEPATOCELLULAR CARCINOMA
IF3.4
err2025-02-01
err0
errOAAI
errFinn, Richard S.; Iyer, Renuka; Kalman, Richard S.; Parikh, Neehar D.; Cabrera, Roniel; Babajanyan, Svetlana; Kaseb, Ahmed O.
err分享
err收藏
Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus墨西哥裔2型糖尿病患者肝细胞癌的风险和预后
errJOURNAL OF HEPATOCELLULAR CARCINOMA
IF3.4
err2025-01-01
err0
errOAAI
errHatia, Rikita I.; Hwang, Lu-Yu; Li, Ruosha; Troisi, Catherine; Jalal, Prasun K.; Amos, Christopher I.; Gomez, Henry F.; Chun, Yun Shin; Rashid, Asif; Kaseb, Ahmed O.; Scheet, Paul A.; Hassan, Manal M.
err分享
err收藏
Type I MET inhibitors cooperate with PD-1 blockade to promote rejection of hepatocellular carcinoma
errJOURNAL FOR IMMUNOTHERAPY OF CANCER
IF10.6
err2024-10-30
err0
errOAAI
errDeAzevedo, Ricardo; Steiner, Madeline; Turner, Broderick X.; Liu, Arthur; Newton, Sherwin; Schmidt, Joanna; Fleming, Rachel; Tolentino, Angelica; Kaseb, Ahmed O.; Curran, Michael A.
err分享
err收藏
Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial
errCLINICAL AND MOLECULAR HEPATOLOGY
IF16.9
err2024-10-01
err1
errOAAI
errYim, Sun Young; Lee, Sung Hwan; Baek, Seung-Woo; Sohn, Bohwa; Jeong, Yun Seong; Kang, Sang-Hee; Park, Kena; Park, Hyewon; Lee, Sunyoung S.; Kaseb, Ahmed O.; Park, Young Nyun; Leem, Sun-Hee; Curran, Michael A.; Kim, Ji Hoon; Lee, Ju-Seog
err分享
err收藏
Analysis of antidrug antibodies (ADA) to camrelizumab in CARES-310: The pivotal phase III study of camrelizumab plus rivoceranib in unresectable hepatocellular carcinoma (uHCC)CARES-310研究：卡瑞利珠单抗（camrelizumab）在不可切除肝细胞癌（uHCC）中联合瑞戈非尼（rivoceranib）的III期关键研究的抗药抗体（ADA）分析
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errKaseb, A. O.; Bugni, J.; Karkhanis, M.; Meng, X.; Wei, T.; Zhou, M.; Shen, K.; Yang, C.; Yu, M.; Jang, S. H.; Ryan, K.; Alexander, L.
err分享
err收藏
Quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis to assess the impact of treatment with camrelizumab plus rivoceranib (cam plus rivo) on quality of life vs sorafenib (sora) in patients (pts) with unresectable hepatocellular carcinoma (uHCC): Study CARES-310质量调整无症状或无毒性时间（Q-TWiST）分析，以评估卡瑞利珠单抗联合瑞戈非尼（cam plus rivo）治疗与索拉非尼（sora）相比，对不可切除肝癌（uHCC）患者（pts）生活质量的影响：CARES-310研究
errANNALS OF ONCOLOGY
IF65.4
err2024-09-01
err0
PREAI
errMoon, A.; Raphael, N.; Chan, S. L.; Kaseb, A. O.; Jang, S. H.; Meng, X.; Cheng, A-L.; Qin, S.; Vogel, A.
err分享
err收藏
Translational modeling-based evidence for enhanced efficacy of standard-of-care drugs in combination with anti-microRNA-155 in non-small-cell lung cancer
errMOLECULAR CANCER
IF33.9
err2024-08-02
err2
errOAAI
errDogra, Prashant; Shinglot, Vrushaly; Ruiz-Ramirez, Javier; Cave, Joseph; Butner, Joseph D.; Schiavone, Carmine; Duda, Dan G.; Kaseb, Ahmed O.; Chung, Caroline; Koay, Eugene J.; Cristini, Vittorio; Ozpolat, Bulent; Calin, George A.; Wang, Zhihui
err分享
err收藏
Utilization of Immunotherapy as a Neoadjuvant Therapy for Liver Transplant Recipients with Hepatocellular Carcinoma
errJOURNAL OF CLINICAL MEDICINE
IF2.9
err2024-05-24
err4
errOAAI
errAbdelrahim, Maen; Esmail, Abdullah; Divatia, Mukul K.; Xu, Jiaqiong; Kodali, Sudha; Victor, David W.; Brombosz, Elizabeth; Connor, Ashton A.; Saharia, Ashish; Elaileh, Ahmed; Kaseb, Ahmed O.; Ghobrial, Rafik Mark
err分享
err收藏

研究方向

暂无研究方向
合作学者
合作期刊
H
Hagop M. Kantarjian
H 指数: 230 · 论文数: 5.5K
J
John C. Morris
H 指数: 212 · 论文数: 2.4K
G
Gregory J. Gores
H 指数: 164 · 论文数: 1.0K
M
Mien‐Chie Hung
H 指数: 163 · 论文数: 1.5K
J
James P. Allison
H 指数: 157 · 论文数: 1.2K
查看更多